GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients
2019 · Cell Communication and Signaling · 56 citations
https://doi.org/10.1186/s12964-019-0467-7
C
Camilla Wolowczyk
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
25
Papers
231
Citations
6
h-index
5
i10-index
Camilla Wolowczyk is an academic researcher from Norwegian University of Science and Technology. The author has contributed to research in topics: Axon Guidance and Neuronal Signaling & Immune cells in cancer & Hereditary Neurological Disorders. The author has an h-index of 6, co-authored 22 publications.
ORCID: 0000-0002-8913-7462Papers by this author
worksNRF2 drives an oxidative stress response predictive of breast cancer
2022 · Free Radical Biology and Medicine · 22 citations
https://doi.org/10.1016/j.freeradbiomed.2022.03.029
A highly selective purine-based inhibitor of CSF1R potently inhibits osteoclast differentiation
2023 · European Journal of Medicinal Chemistry · 13 citations
https://doi.org/10.1016/j.ejmech.2023.115344
Discovery of a new marker to identify myeloid cells associated with metastatic breast tumours
2023 · Cancer Cell International · 4 citations
https://doi.org/10.1186/s12935-023-03136-w
Elucidating the power of arginine restriction: taming type I interferon response in breast cancer via selective autophagy
2024 · Cell Communication and Signaling · 1 citations
https://doi.org/10.1186/s12964-024-01858-6
406 (PB394): Exploring peptide derived from Signaling Lymphocytic Activation Molecule-1 as a novel anti-cancer treatment for multiple myeloma
2024 · European Journal of Cancer · 0 citations
https://doi.org/10.1016/j.ejca.2024.114918
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat